Kadcyla 160 mg Injection

Manufacturer Roche Products India Pvt Ltd
Composition Ado-trastuzumab emtansine (160mg)
Type Injection
…… …….
…….. ………

How to use Kadcyla 160 mg Injection

Your medical professional or nurse will offer you this medication. Kindly do not self-administer.


How Kadcyla 160 mg Injection works in the body

According to scientific research, this medicine works in the body per below(ME/1)

This medication is an anti-cancer medication. It binds to HER2 receptors on bust cancer cells and also flags the cancer cells for devastation by the body’s body immune system. It likewise enters into the cancer cells to launch a radiation treatment medication (emtansine) and also quit them from expanding and also separating.


….

What are the Side effects of Kadcyla 160 mg Injection

Scientific studies indicate, below mentioned side effects may occur while taking this medicine such as(ME/2)

  • Tiredness
  • Nausea
  • Musculoskeletal (bone, muscle or joint) pain
  • Bleeding
  • Low blood platelets
  • Headache
  • Liver disorder
  • Constipation
  • Nosebleeds

Precautions to be taken while taking Kadcyla 160 mg Injection

As per several scientific studies, some precautions need to be taken while taking this medicine such as(ME/3)

  1. Not enough or limited scientific data available for interaction with food of this medicine, or read the label of the pack to understand about if any interaction may occur if taken with food.

Safety instructions before taking Kadcyla 160 mg Injection

  • Alcohol : Limited information available : Interaction with alcohol is unknown. Please consult doctor before consuming this medicine.
  • Pregnancy : Doing comparison of advantage and also risk is called for: This medicine is unsafe to utilize during pregnancy. There is positive evidence of human fetal threat, but the gain from use in pregnant women might serve despite the risk, for example in lethal circumstances. Please speak with physician prior to eating this medicine.
  • Lactation : Harmful: This medicine is dangerous to use throughout lactation. Data recommends that the medicine may create toxicity to the child, or the mommy is struggling with a problem in which breastfeeding is not advisable.
  • Kidney : Limited details offered: There is limited information offered on making use of this medicine in people with kidney condition. Please consult doctor before consuming this medicine.
  • Liver : Caution called for: This medicine should be made use of with care in individuals with extreme liver illness. Dosage modification of this medication may be needed. Please seek advice from doctor before eating this medicine.
  • Driving : Safe: This medication does not generally impact your ability to drive.

Frequently asked questions

Q: What is the use of This medication?

Q: How is This medicine different?

A: This medicine is a conjugate of the HER2 directed trastuzumab and a highly toxic microtubule-tarobtained medicine (emtansine). Thus it is made up of 2 cancer-fighting agents in 1 medicine- The monoclonal antibody trastuzumab and a chemotherapy emtansine. This medicine brings chemotherapy medicine (emtansine) into HER2-positive cells and kills them. It is designed to cause less harm to normal cells.

Q: What should i do if i forgot to take Kadcyla 160 mg Injection

A: What happens if you miss out on a dose of this medicine, please consult your medical professional.


Related Content

…..